User Community

Advertisement

Quality Experts
@quality-experts
Eminent Member
Joined: Apr 15, 2025
Last seen: Jan 29, 2026
Topics: 0 / Replies: 37
Reply
RE: Forced Degradation Testing: Timing, Design, and ELISA CAR Assay Studies

I have no experience with CAR and ELISA assay forced degradation. Available guidance, such as the Brazilian ANVISA, Guideline No. 04/2015 focus on che...

1 month ago
Reply
RE: MODR Filing Examples: Companies Submitting Method Operable Design Regions

I do not have specific information, but I have heared that Pfizer and GSK filed MODRs.   Join Dr. Joachim Ermer (Ermer Quality Consulting) to...

1 month ago
Reply
RE: Validation as Continuous State vs One-Off Activity: Modern Approach

Yes, that's perfectly true. The initial validation should be regarded as a starting point, i.e. the formal approval of the analytical procedure for pr...

1 month ago
Reply
RE: ICH Extrapolation Guidelines: Using Limited Samples Beyond Specification Range

The guideline does not go into details. Of course, you have to take the samples and ranges available or accessible. Whether or not to extrapolate by c...

1 month ago
Reply
RE: Total Error Uncertainty: Prediction vs Tolerance Intervals and Sample Size

In principle, this is a prediction interval, but it's referred in the statistical literature as beta-expectation tolerance intervals, in opposition to...

1 month ago
Reply
RE: Setting Confidence Intervals for Precision Testing in Early Development

CI are required for validation submission. Once you can compute them, there is no reason to not always report them, even if only for information. The ...

1 month ago
Reply
RE: Risk Assessment Before Validation: Can You Skip Low-Risk Parameters?

I would always make a risk assessment and identify the method type (impurity, quantitative, etc.) to ensure the relevant parameters are computed. &n...

1 month ago
Reply
RE: Determining optimal replicates for cell-based assay validation

It's possible to compute the intermediate precision (IP) or total analytical error (TAE) for a reportable value computed from replicates. Hence, if on...

1 month ago
Reply
RE: Statistical Tools & Software for Analytical Development

The equivalence test TOTS is included in minitab from version 17. Join Dr Francisca Galindo Garre from Johnson & Johnson Innovative Medicine...

6 months ago
Reply
RE: Method Comparability and Statistics for Analytical Development

The criterium 3 SD is commonly used for Bland-Altman plot. Note that this criterion should include 99.99% of differences. It is also important to chec...

6 months ago
Reply
RE: Equivalence Testing

To set equivalence limits we should take into account which differences are scientifically relevant and also the variation of the methods that we are ...

6 months ago
Reply
RE: Bridging of methods or critical materials

Generally, I think it is essential to distinguish a method bridging from an instrument change. For method bridging (moving from one analytical method ...

6 months ago
Reply
RE: Vendor support when updating analytical procedures

The interest by manufacturers to support users is very well appreciated. I think first of all an active exchange is beneficial in all cases. Generally...

6 months ago
Reply
RE: Instruments updates and method validation

ICH Q2R2 chapter 2.2 offers three scenarios that depend on the degree of performance differences between the two instruments. In case the readout is c...

6 months ago
Reply
RE: Established conditions CGT

The use of EC, or rather avoiding that the ECs are not too extensive, is not related to the modality, I think, but rather the amount of knowledge. It ...

6 months ago
Page 1 / 3

Advertisement

Advertisement

Advertisement